ALX Oncology CMO Sophia Randolph Announces Resignation
Company Announcements

ALX Oncology CMO Sophia Randolph Announces Resignation

ALX Oncology Holdings ( (ALXO) ) has shared an update.

Sophia Randolph, the Chief Medical Officer of ALX Oncology Holdings Inc., has announced her resignation to seek new professional avenues, effective October 11, 2024. Her departure is amicable, with no disputes over company operations. ALX Oncology is set to look for her replacement and has agreed to a generous separation package for Dr. Randolph, including a lump sum payment, extended health benefits, full vesting of certain stock options, and a consulting agreement to aid in the transition. This move is a forward-looking statement and carries the usual risks associated with such changes in management.

For an in-depth examination of ALXO stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskALX Oncology Highlights Promising Trial Results
TipRanks Auto-Generated NewsdeskALX Oncology Reports Clinical Progress and Financial Stability
TheFlyALX Oncology reports Q3 EPS (58c) consensus (78c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App